Foresight Group a leading regional private equity and infrastructure investment manager, has announced a £3 million investment into MyWay Digital Health a digital healthcare solutions provider dedicated to reducing the burden of chronic disease, with a particular emphasis on diabetes.
Spun out of the University of Dundee in 2017, MWDH employs 30 staff across Dundee, Edinburgh, and London. The Company’s mission is to improve the lives of individuals living with long-term conditions through cost-effective, data-driven, personalised health technology. Its suite of products spans diabetes prevention, cardiovascular health, hypertension, and weight management.
MWDH’s flagship platform, MyWay Diabetes, is a clinically validated digital self-management tool that integrates with NHS systems to provide personalised education, data visualisation, and actionable insights for patients and clinicians. The platform has been adopted across multiple NHS regions and internationally, demonstrating measurable improvements in patient engagement and health outcomes.
Foresight’s investment will enable MWDH to accelerate the development of new AI-enabled products, including predictive analytics and personalised care pathways, while expanding its commercial footprint to meet growing global demand for scalable digital health solutions.
To support the Company’s growth strategy, Dr Umang Patel will join as Non-Executive Chair. Dr Patel brings extensive experience from the technology and healthcare sectors and currently serves as Chief Clinical Information Officer for Microsoft in the EMEA region. He will work closely with the management team to drive both domestic and international expansion.
